Cardium Therapeutics announced that its Chairman and CEO, Christopher J. Reinhard, will be one of the presenters at the Marcum MicroCap Conference on June 20, 2012, at 11:00 a.m. Eastern Time. A live audio webcast and replay of the presentation will be available to all investors at http://execvid.com/marcum-microcap-conference-2012. The company has already made the investor presentation available on its Web site at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.
Held at the Roosevelt Hotel in New York City, the Marcum MicroCap Conference was put together for investors who are interested in micro-cap investments. The conference is expected to attract over 500 participants, including institutional investors, mutual funds, hedge funds, wealth managers, and family offices. The conference will also feature panels on subjects highly relevant to small-cap corporate finance. For more event details and registration information, please visit http://www.marcumllp.com/MicroCap.
Cardium, a health sciences and regenerative medicine company, is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering, and other economic monetizations. The company’s current medical opportunities portfolio includes the Tissue Repair Company, Cardium Biologics, and the company’s in-house MedPodium Health Sciences healthy lifestyle product platform. To learn more about the company, visit www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
